187 related articles for article (PubMed ID: 22735528)
1. Cell-intrinsic functional effects of the α-cardiac myosin Arg-403-Gln mutation in familial hypertrophic cardiomyopathy.
Chuan P; Sivaramakrishnan S; Ashley EA; Spudich JA
Biophys J; 2012 Jun; 102(12):2782-90. PubMed ID: 22735528
[TBL] [Abstract][Full Text] [Related]
2. Functional effects of the hypertrophic cardiomyopathy R403Q mutation are different in an alpha- or beta-myosin heavy chain backbone.
Lowey S; Lesko LM; Rovner AS; Hodges AR; White SL; Low RB; Rincon M; Gulick J; Robbins J
J Biol Chem; 2008 Jul; 283(29):20579-89. PubMed ID: 18480046
[TBL] [Abstract][Full Text] [Related]
3. Hypertrophic cardiomyopathy β-cardiac myosin mutation (P710R) leads to hypercontractility by disrupting super relaxed state.
Vander Roest AS; Liu C; Morck MM; Kooiker KB; Jung G; Song D; Dawood A; Jhingran A; Pardon G; Ranjbarvaziri S; Fajardo G; Zhao M; Campbell KS; Pruitt BL; Spudich JA; Ruppel KM; Bernstein D
Proc Natl Acad Sci U S A; 2021 Jun; 118(24):. PubMed ID: 34117120
[TBL] [Abstract][Full Text] [Related]
4. Myofilament mechanical performance is enhanced by R403Q myosin in mouse myocardium independent of sex.
Palmer BM; Wang Y; Teekakirikul P; Hinson JT; Fatkin D; Strouse S; Vanburen P; Seidman CE; Seidman JG; Maughan DW
Am J Physiol Heart Circ Physiol; 2008 Apr; 294(4):H1939-47. PubMed ID: 18281382
[TBL] [Abstract][Full Text] [Related]
5. Hypertrophic cardiomyopathy associated Lys104Glu mutation in the myosin regulatory light chain causes diastolic disturbance in mice.
Huang W; Liang J; Kazmierczak K; Muthu P; Duggal D; Farman GP; Sorensen L; Pozios I; Abraham TP; Moore JR; Borejdo J; Szczesna-Cordary D
J Mol Cell Cardiol; 2014 Sep; 74():318-29. PubMed ID: 24992035
[TBL] [Abstract][Full Text] [Related]
6. Differential cross-bridge kinetics of FHC myosin mutations R403Q and R453C in heterozygous mouse myocardium.
Palmer BM; Fishbaugher DE; Schmitt JP; Wang Y; Alpert NR; Seidman CE; Seidman JG; VanBuren P; Maughan DW
Am J Physiol Heart Circ Physiol; 2004 Jul; 287(1):H91-9. PubMed ID: 15001446
[TBL] [Abstract][Full Text] [Related]
7. Transgenic mouse α- and β-cardiac myosins containing the R403Q mutation show isoform-dependent transient kinetic differences.
Lowey S; Bretton V; Gulick J; Robbins J; Trybus KM
J Biol Chem; 2013 May; 288(21):14780-7. PubMed ID: 23580644
[TBL] [Abstract][Full Text] [Related]
8. Insights into human beta-cardiac myosin function from single molecule and single cell studies.
Sivaramakrishnan S; Ashley E; Leinwand L; Spudich JA
J Cardiovasc Transl Res; 2009 Dec; 2(4):426-40. PubMed ID: 20560001
[TBL] [Abstract][Full Text] [Related]
9. The familial hypertrophic cardiomyopathy-associated myosin mutation R403Q accelerates tension generation and relaxation of human cardiac myofibrils.
Belus A; Piroddi N; Scellini B; Tesi C; D'Amati G; Girolami F; Yacoub M; Cecchi F; Olivotto I; Poggesi C
J Physiol; 2008 Aug; 586(15):3639-44. PubMed ID: 18565996
[TBL] [Abstract][Full Text] [Related]
10. Hypertrophic cardiomyopathy R403Q mutation in rabbit β-myosin reduces contractile function at the molecular and myofibrillar levels.
Lowey S; Bretton V; Joel PB; Trybus KM; Gulick J; Robbins J; Kalganov A; Cornachione AS; Rassier DE
Proc Natl Acad Sci U S A; 2018 Oct; 115(44):11238-11243. PubMed ID: 30322937
[TBL] [Abstract][Full Text] [Related]
11. Early-Onset Hypertrophic Cardiomyopathy Mutations Significantly Increase the Velocity, Force, and Actin-Activated ATPase Activity of Human β-Cardiac Myosin.
Adhikari AS; Kooiker KB; Sarkar SS; Liu C; Bernstein D; Spudich JA; Ruppel KM
Cell Rep; 2016 Dec; 17(11):2857-2864. PubMed ID: 27974200
[TBL] [Abstract][Full Text] [Related]
12. The hypertrophic cardiomyopathy mutations R403Q and R663H increase the number of myosin heads available to interact with actin.
Sarkar SS; Trivedi DV; Morck MM; Adhikari AS; Pasha SN; Ruppel KM; Spudich JA
Sci Adv; 2020 Apr; 6(14):eaax0069. PubMed ID: 32284968
[TBL] [Abstract][Full Text] [Related]
13. Single-molecule mechanics of R403Q cardiac myosin isolated from the mouse model of familial hypertrophic cardiomyopathy.
Tyska MJ; Hayes E; Giewat M; Seidman CE; Seidman JG; Warshaw DM
Circ Res; 2000 Apr; 86(7):737-44. PubMed ID: 10764406
[TBL] [Abstract][Full Text] [Related]
14. Effects of hypertrophic and dilated cardiomyopathy mutations on power output by human β-cardiac myosin.
Spudich JA; Aksel T; Bartholomew SR; Nag S; Kawana M; Yu EC; Sarkar SS; Sung J; Sommese RF; Sutton S; Cho C; Adhikari AS; Taylor R; Liu C; Trivedi D; Ruppel KM
J Exp Biol; 2016 Jan; 219(Pt 2):161-7. PubMed ID: 26792326
[TBL] [Abstract][Full Text] [Related]
15. Hypertrophic and dilated cardiomyopathy mutations differentially affect the molecular force generation of mouse alpha-cardiac myosin in the laser trap assay.
Debold EP; Schmitt JP; Patlak JB; Beck SE; Moore JR; Seidman JG; Seidman C; Warshaw DM
Am J Physiol Heart Circ Physiol; 2007 Jul; 293(1):H284-91. PubMed ID: 17351073
[TBL] [Abstract][Full Text] [Related]
16. Pathogenesis of Hypertrophic Cardiomyopathy is Mutation Rather Than Disease Specific: A Comparison of the Cardiac Troponin T E163R and R92Q Mouse Models.
Ferrantini C; Coppini R; Pioner JM; Gentile F; Tosi B; Mazzoni L; Scellini B; Piroddi N; Laurino A; Santini L; Spinelli V; Sacconi L; De Tombe P; Moore R; Tardiff J; Mugelli A; Olivotto I; Cerbai E; Tesi C; Poggesi C
J Am Heart Assoc; 2017 Jul; 6(7):. PubMed ID: 28735292
[TBL] [Abstract][Full Text] [Related]
17. Altered crossbridge kinetics in the alphaMHC403/+ mouse model of familial hypertrophic cardiomyopathy.
Blanchard E; Seidman C; Seidman JG; LeWinter M; Maughan D
Circ Res; 1999 Mar; 84(4):475-83. PubMed ID: 10066683
[TBL] [Abstract][Full Text] [Related]
18. Three perspectives on the molecular basis of hypercontractility caused by hypertrophic cardiomyopathy mutations.
Spudich JA
Pflugers Arch; 2019 May; 471(5):701-717. PubMed ID: 30767072
[TBL] [Abstract][Full Text] [Related]
19. The molecular phenotype of human cardiac myosin associated with hypertrophic obstructive cardiomyopathy.
Jacques AM; Briceno N; Messer AE; Gallon CE; Jalilzadeh S; Garcia E; Kikonda-Kanda G; Goddard J; Harding SE; Watkins H; Esteban MT; Tsang VT; McKenna WJ; Marston SB
Cardiovasc Res; 2008 Aug; 79(3):481-91. PubMed ID: 18411228
[TBL] [Abstract][Full Text] [Related]
20. R403Q and L908V mutant beta-cardiac myosin from patients with familial hypertrophic cardiomyopathy exhibit enhanced mechanical performance at the single molecule level.
Palmiter KA; Tyska MJ; Haeberle JR; Alpert NR; Fananapazir L; Warshaw DM
J Muscle Res Cell Motil; 2000; 21(7):609-20. PubMed ID: 11227787
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
